Rebalix
Logo XtrackersXtrackers · sheet of 10 September 2026
ETF sheet · official issuer and register data

Xtrackers Msci Global Sdgs UCITS ETF 1c

IE000PSF3A70 · IE000PSF3A70 · USD · domicile Ireland
Equity · Global · All sizesSFDR art. 8
Index tracked: MSCI ACWI IMI SDG Impact Select Index (USD)
TER
0.35%+ trans. 0.03%
Fund size
6 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 18 Jan 2023 · costs from the KID as of 2 Sept 2026 · 235 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed. INVESTMENT OBJECTIVE: The aim is for your investment to track the performance of the MSCI ACWI IMI SDG Impact Select Index (index). DESCRIPTION OF INDEX: The index is based on the MSCI ACWI IMI Index (Parent Index) and is designed to reflect the performance of the shares of large, medium, and small-capitalisation companies globally that are associated with a positive contribution to the United Nations Sustainable Development Goals (SDGs). In order to be eligible for inclusion companies must be eligible for inclusion in…

Performance since series start (in euro) — base 100

18 Jan 20238 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
20242025202610880104
High 108 (3 Jun 2026) · low 80 (8 Apr 2025) · last 104. Past performance is not indicative of future results.

Returns in euro

1 year+13.6%
3 years+12.3%
5 yearsseries too young
10 yearsseries too young
Since series start+4.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.25%13.63%
Max drawdown−8.12%−18.80%
Sharpe0.800.30
Sortino1.190.42
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE000PSF3A70 · IE000PSF3A701
RebalixIE000PSF3A70 · IE000PSF3A70 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+13.70%+13.99%−0.29%
2024−6.30%−6.08%−0.23%

Holdings

Portfolio as declared by the issuer · 2 Sept 2026 · 235 securities · top-10 weight = 31.5%
Top holdingsWeight
NVIDIA4.4%
GILEAD SCIENCES4.3%
MARVELL TECHNOLOGY4.1%
VERTEX PHARMACEUTICALS3.4%
FIRST SOLAR3.2%
BRISTOL MYERS SQUIBB3.2%
VESTAS WIND SYSTEMS2.8%
KIMBERLY CLARK2.2%
WIWYNN CORPORATION2.2%
REGENERON PHARMACEUTICALS1.8%
Countries (% of fund)
United States49.3%China8.6%Japan7.2%Denmark3.8%Taiwan3.4%
Sectors (% of fund)
Health Care24.0%Information Technology18.4%Industrials14.8%Real Estate13.0%Consumer Staples12.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
XDGI · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 12 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · etf.dws.com/download/asset/cf9c5de4-e544-4dd0-b994-5a25483f2c5c
Factsheet · etf.dws.com/download/asset/46ffa23e-60c4-4942-9a35-4006746f2494
Prospectus · etf.dws.com/download/asset/25f159fa-a123-4a77-9751-682976c15095
The live sheet, always up to date
rebalix.com/en/etf/IE000PSF3A70
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · IE000PSF3A70 · IE000PSF3A702